Skip to main content

Table 1 Demographics of participants and medical characteristics of patients upon PICU admission

From: Time course of altered DNA methylation evoked by critical illness and by early administration of parenteral nutrition in the paediatric ICU

 

PICU patients

Healthy controls

p value

PICU patients

Early-PN

PICU patients

Late-PN

p value

n = 42

n = 42

n = 36

n = 36

Demographics

      

Age (mean ± SEM)—years

3.9 ± 0.6

3.8 ± 0.5

0.93

2.6 ± 0.7

2.1 ± 0.5

0.57

Infant (age < 1 year)—no. (%)

14 (33)

10 (24)

0.33

22 (61)

22 (61)

1.00

Sex

  

0.82

  

0.81

 Female—no. (%)

21 (50)

22 (48)

 

15 (42)

14 (39)

 

 Male—no. (%)

21 (50)

20 (52)

 

21 (58)

22 (61)

 

Socio-economic statusa

      

Educational level of the parents

  

  

0.13

 Parents educational level 1.5—no. (%)

3 (7)

NA

 

4 (11)

1 (3)

 

 Parents educational level 2—no. (%)

10 (24)

NA

 

11 (31)

9 (25)

 

 Parents educational level 2.5—no. (%)

6 (14)

NA

 

4 (11)

7 (19)

 

 Parents educational level 3—no. (%)

10 (24)

NA

 

6 (17)

13 (36)

 

 Parents educational level unknown—no. (%)

13 (31)

NA

 

11 (31)

6 (17)

 

Occupational level of the parents

  

  

0.28

 Parents occupational level 1.5—no. (%)

2 (5)

NA

 

2 (6)

2 (6)

 

 Parents occupational level 2—no. (%)

8 (19)

NA

 

8 (22)

8 (22)

 

 Parents occupational level 2.5—no. (%)

2 (5)

NA

 

2 (6)

3 (8)

 

 Parents occupational level 3—no. (%)

7 (17)

NA

 

5 (14)

9 25)

 

 Parents occupational level 3.5—no. (%)

1 (2)

NA

 

1 (3)

0 (0)

 

 Parents occupational level 4—no. (%)

5 (12)

NA

 

3 (8)

7 (19)

 

 Parents occupational level unknown—no. (%)

17 (40)

NA

 

15 (41)

7 (19)

 

Patient characteristics upon PICU admission

      

Weight z-score (mean ± SEM)

− 0.45 ± 0.23

NA

− 0.48 ± 0.21

− 0.41 ± 0.25

0.84

Height z-score (mean ± SEM)

− 0.63 ± 0.34

NA

− 0.61 ± 0.28

− 0.21 ± 0.36

0.39

STRONGkids risk levelb

  

  

0.15

 Medium—no. (%)

38 (90)

NA

 

35 (97)

32 (89)

 

 High—no. (%)

4 (10)

NA

 

1 (3)

4 (11)

 

PeLOD score first 24 h in PICU (mean ± SEM)c

28.3 ± 1.4

NA

29.4 ± 1.5

30.0 ± 1.2

0.72

PIM3 score (mean ± SEM)d

− 3.06 ± 0.17

NA

− 2.87 ± 0.20

− 3.23 ± 0.12

0.13

Infection upon PICU admission

14 (33)

NA

9 (25)

9 (25)

1.00

Diagnostic categorye

 

NA

  

0.23

 Surgical-cardiac—no. (%)

23 (55)

NA

 

24 (67)

27 (75)

 

 Surgical-other—no. (%)

4 (10)

NA

 

3 (8)

2 (6)

 

 Neurosurgery/neurology—no. (%)

6 (14)

NA

 

4 (11)

2 (6)

 

 Trauma/burn—no. (%)

1 (2)

NA

 

0 (0)

1 (3)

 

 Transplantation/haematology/oncology—no. (%)

2 (5)

NA

 

1 (3)

1 (3)

 

 Medical-other—no. (%)

6 (14)

NA

 

4 (11)

3 (8)

 

History of malignancy—no. (%)

5 (12)

NA

3 (8)

2 (6)

0.64

Diabetes—no. (%)

0 (0)

NA

0 (0)

0 (0)

Predefined syndrome—no. (%)f

8 (19)

NA

8 (22)

3 (8)

0.09

Randomisation

      

Early-PN—no. (%)

19 (45)

NA

36 (100)

0 (0)

Late-PN—no. (%)

23 (55)

NA

0 (0)

36 (100)

  1. PN parenteral nutrition, SEM standard error of the mean, PICU paediatric intensive care unit, STRONGkids screening tool for risk on nutritional status and growth, PeLOD paediatric logistic organ dysfunction, PIM3 paediatric index of mortality 3
  2. aThe educational and occupational level is the mean of the paternal and maternal educational or occupational level (Additional file 1)
  3. bSTRONGkids scores range from 0 to 5, with a score of 0 indicating a low risk of malnutrition, a score of 1–3 indicating a medium risk, and a score of 4–5 indicating a high risk
  4. cPeLOD scores range from 0 to 71, with higher scores indicating more severe illness
  5. dHigher PIM3 scores indicate a higher risk of mortality
  6. e‘Surgical-other’ includes abdominal, thoracic or, other surgery. ‘Medical-other’ includes cardiac, gastrointestinal or hepatic, renal, respiratory or, other medical problems
  7. fA predefined syndrome is any pre-randomisation syndrome or illness a priori defined as affecting or possibly affecting neurocognitive development (Additional file 2)